Ratings by Rodman & Renshaw
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 7/7/2026 | Michael King Jr. | Atossa Genetics | ATOS | New Coverage | Buy (N/A) |
12.00 (N/A) |
2.28 (2.49) |
9.21% | Details |
| 6/30/2026 | Michael King Jr. | vTv Therapeutics | VTVT | New Coverage | Buy (N/A) |
67.00 (N/A) |
36.27 (32.88) |
-9.35% | Details |
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 79 more... | |||||||||


